IGRA

QuantiFERON SARS-CoV-2 features trusted QuantiFERON technology to measure cell-mediated immune response after SARS-CoV-2 vaccination.
• Leverages reliable, established QuantiFERON IGRA workflow
• Highly specific CD4 and CD8 T cell responses
• Flexible workflow: up to 53 hours available from sample collection to incubation
• CE-IVD marked